2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Refractory AML: new trials by email Literature Review of Refractory AML trials Research Report on Refractory AML
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX) Venetoclax Oral Tablet - Relapsed Adult AML, Refractory AML | Phase 1 / Phase 2 | Completed | Technische Universität Dresden | 55 | 2020-04-06 | 2026-09-02 |
| Phase 1 Study of Quizartinib AC220 - Relapsed AML, Refractory AML | Phase 1 | Completed | Daiichi Sankyo Co., Ltd. | 17 | 2016-02-01 | 2019-02-12 |
Leukemia, Myeloid, Acute (2) · Neoplasms (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Leukemia (2) · Leukemia, Myeloid (2) · Neoplasms by Histologic Type (2) · Neoplasms (1)
venetoclax (1)
Daiichi Sankyo Co., Ltd. (1) · Technische Universität Dresden (1)
Germany (1) · Japan (1)